Daclatasvir

Chemical formula: C₄₀H₅₀N₈O₆  Molecular mass: 738.89 g/mol  PubChem compound: 25154714

Active ingredient description

Daclatasvir is an inhibitor of nonstructural protein 5A (NS5A), a multifunctional protein that is an essential component of the HCV replication complex. Daclatasvir inhibits both viral RNA replication and virion assembly.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J05AP07 J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP07

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 1009119-64-5
DrugBank Drug: DB09102
KEGG Drug: D10105
PubChem Compound: 25154714
RxNorm Ingredient: 1606218
SNOMED-CT Concept: 712519008
Daclatasvir (substance)
UNII Identifier: LI2427F9CI
DACLATASVIR

Medicines

Daclatasvir is an active ingredient of these brands:

Brazil (BR)

Estonia (EE)

Hong Kong (HK)

Lithuania (LT)

Nigeria (NG)

  • VIRDAC as DACLATASVIR DIHYDROCHLORIDE
  • (combination) MYHEP DVIR as DACLATASVIR DIHYDROCHLORIDE

Poland (PL)

Singapore (SG)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈